Search

Displaying results 6811 - 6820 of 10000 in total
  1. Drug

    Poseltinib

    go.drugbank.com/drugs/DB16299
    Investigational

    Poseltinib is under investigation in clinical trial NCT02628028 (A Study of LY3337641 in Rheumatoid Arthritis).

  2. Drug

    Sodelglitazar

    go.drugbank.com/drugs/DB16332
    Investigational

    Sodelglitazar is under investigation in clinical trial NCT00196989 (Study in People With Type 2 Diabetes).

  3. Drug

    EMI-137

    go.drugbank.com/drugs/DB19174
    Investigational

    EMI-137 is under investigation in clinical trial NCT03360461 (EMI-137 in Laparoscopic Colonic Resections).

  4. Drug

    Troriluzole

    go.drugbank.com/drugs/DB15079
    Investigational

    Troriluzole is under investigation in clinical trial NCT03701399 (Troriluzole in Adult Subjects With Spinocerebellar Ataxia).

  5. Drug

    Vopratelimab

    go.drugbank.com/drugs/DB15378
    Investigational

    Vopratelimab is under investigation in clinical trial NCT02904226 (JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors).

  6. Drug

    CITY-RBP4

    go.drugbank.com/drugs/DB34001
    Experimental

    CITY-RBP4 is under investigation in clinical trial NCT07836452 (A Phase 1, First-in-Human Study of CITY-RBP4 in Healthy Volunteers and STGD1 Participants).

  7. Drug

    Opaganib

    go.drugbank.com/drugs/DB12764
    Investigational

    [L27436] This drug has potential anticancer, anti-inflammatory, and antiviral activities, with potential applications in oncology, inflammation, the gastrointestinal system, and COVID-19.

  8. Drug

    Tefibazumab

    go.drugbank.com/drugs/DB16378
    Investigational

    Tefibazumab is under investigation in clinical trial NCT00198289 (Aurexis® in Cystic Fibrosis Subjects Chronically Colonized With Staphylococcus Aureus in Their Lungs).

  9. Drug

    Garivulimab

    go.drugbank.com/drugs/DB16670
    Investigational

    Garivulimab is under investigation in clinical trial NCT03379259 (Study of BGB-A333 Alone and in Combination With Tislelizumab in Advanced Solid Tumors).

  10. Drug

    Sacrosidase

    go.drugbank.com/drugs/DB06760
    Approved

    People with CSID have variable amounts of sucrose-isomaltase enzyme activity and therefore have issues metabolizing dietary disaccharide sucrose causing chronic or intermittent watery diarrhea in infants